Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001193805-16-002402

Options or other derivatives

  • Chief Financial Officer acquired 5,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
LENZ BRIAN Chief Financial Officer 2016-01-28 Grant or award · Options to purchase +5,750 5,750 D: show line 1 in the form
Loading xslF345X03/e614449_4-lenz.xml…